|
|
楼主 |
发表于 2025-2-6 15:36:45
|
显示全部楼层
本帖最后由 NatureBoy 于 2025-2-6 16:03 编辑 ! \ C& J( x& ^4 ?7 `
$ Z- x, B. g0 n9 n
今年的ISC大会Late-Breaking Science（重磅研究）已经出炉，国内单位入选情况
6 T3 O4 f) k7 t$ b8 Z8 U3 T; d5 q( c' N$ I0 N& s) k z) P
LB2. TransRadial versus transfemoral Arterial access for CErebral angiography9 v5 E1 W; z; k& D2 d" ~7 P
Wei Ni, Huashan Hospital, Fudan University, Shanghai, China
5 z l7 S: s. h# R( Q: w$ K1 p8 Q! c3 d% B0 I0 `6 B3 |
LB17. Intensive Blood Pressure Lowering After Thrombectomy in Ischemic Stroke Patients-A Randomized Clinical Trial
# G) J3 V$ X$ ]2 b, `Xuening Zhang, West China Hospital, Sichuan University, Chendu, China
$ h {" B1 m9 r* e! g% w6 U- r0 _$ ~ c% }
LB38. Intra-arterial Tenecteplase thrombolysis for acute LVO after successful mechanical thrombectomy recanalization (ANGEL-TNK) — A Multicenter, Prospective, Randomized, Open-label, Blinded End-point Trial+ k# s( r5 I2 d. {
Miao Zhongrong, Beijing Tiantan Hospital, Beijing, China. l/ `0 `7 _( M
e( ]" H6 y' j* b. J' w/ ^( XLB39. The Optimal Dosage of ADjunctive Intra-Arterial Tenecteplase following Successful Endovascular Thrombectomy in Patients with Large Vessel Occlusion Acute Ischemic Stroke (DATE) Trail
* E* X1 ~+ t7 r9 O2 SXianhua Hou, The First Affiliated Hospital, Army Medical University, Chongqing, China/ X( J! k* Z* I+ a4 Y" |
. x7 Y1 l, R7 c, _4 j" Z) ^
LB41. Treatment with intravenous alteplase in ischemic stroke patients with onset time between 4.5 and 24 hours
4 Q. q- L1 A, w& t( _8 zMin Lou, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China
, q: V7 O) b0 _$ R" b$ z: s% y$ j! x; n- S" e8 m7 [! \4 q
LB42. Intra-arterial Alteplase for Acute Ischemic Stroke After Mechanical Thrombectomy (PEARL): A Multicenter Randomized Trial
" x! E' b1 k0 ], \Yamei Tang, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
+ ^; m4 `5 z5 |. A
0 l: y, X0 ^6 m8 ]LB44. Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients with Type 2 Diabetes Mellitus (LAMP): A Randomized Clinical Trial1 y7 J1 r# L! ]* P7 h
Huili Zhu, The First Affiliated Hospital of Jinan University, Guangzhou, China% e7 A, K* e: i; G+ S
4 N: }' [) f% {' N+ N8 I& YLB45. BXOS110 for Acute Ischemic Stroke Treatment (BEST): A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
& U9 l* z; A* P, }( ~9 }Yarong Ding, Beijing Tiantan Hospital, Beijing, China7 z V( N' g+ U4 C7 F
' j _# o9 [) s j# ?3 e9 m: u( R
祝贺以上单位！
- n$ u: } M0 e( i( `9 s' w& r |
|
发表于 2025-2-6 15:11:41
发表于 2025-2-6 15:40:38
